Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS

Neurobiology of Aging

Volumn 21, Issue 1, 2000, Pages 57-62

  Petrovitch, H ^a,b   White, L R ^a,b   Izmirilian, G ^b   Ross, G W ^a,b,c   Havlik, R J ^b   Markesbery, W ^d,e   Nelson, J ^f   Davis, D G ^d,e   Hardman, J ^g   Foley, D J ^b   Launer, L J ^b  

^a KUAKINI MEDICAL CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d Department of Veteran's Affairs ^*  (United States)

^e LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Hypertension; Neuropathology; Population based longitudinal study

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; BRAIN WEIGHT; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ASIAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; ATROPHY; BLOOD PRESSURE; BRAIN; BRAIN DISEASES; COHORT STUDIES; COMORBIDITY; DIASTOLE; HAWAII; HIPPOCAMPUS; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLES; ORGAN SIZE; SENILE PLAQUES; SYSTOLE;

EID: 0034594470     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00106-8     Document Type: Article

References (38)

1. Akashi T., Arima K., Maruyama N., Ando S., Inose T. Severe cerebral atrophy in progressive supranuclear palsy a case report . Clin Neuropathol. 8:1989;195-199.
2. Akiyama H., Meyer J.S., Mortel K.F., Terayama Y., Thornby J.I., Konno S. Normal human aging factors contributing to cerebral atrophy . J Neurol Sci. 152:1997;39-49.
3. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. 1987;American Psychiatric Association, Washington, DC.
4. Baumbach G.L. Changes in the cerebral circulation in chronic hypertension. Bevan R.D., Bevan J.A., The Human Brain Circulation. 1994;421-431 Humana Press, Clifton, NJ.
5. Breslow N.E. Tests of hypotheses in over dispersed poison regression and other quasi-likelihood models. J Am Statist Assoc. 85:1990;565-571.
6. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 42:1992;473-480.
7. Crawford F., Suo Z., Fang C., Mullan M. Characteristics of the in vitro vasoactivity of beta-amyloid peptides. Exp Neurol. 150:1998;159-168.
8. DeCarli C., Miller B.L., Swan G.E., et al. Predictors of brain morphology for the men of the NHLBI twin study. Stroke. 30:1999;529-536.
9. Elias M.F., Wolf P.A., D'Agostino R.B., Cobb J., White L.R. Untreated blood pressure level is inversely related to cognitive functioning the Framingham Study . Am J Epidemiol. 138:1993;353-364.
10. Erkinjuntti T., Hachinski V.C. Rethinking vascular dementia. Cerebrovasc Dis. 3:1993;3-23.
11. Erkinjuntti T, Haltia M, Palo J, Paetu A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiat 1988;51:1037-44. Abstract.
12. Ghika J., Bogousslavsky J. Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy. Arch Neurol. 54:1997;1104-1108.
13. Hansen P.S., Gerdes L.U., Klausen I.C., Gregersen N., Faergeman O. Genotyping compared with protein phenotyping of the common apolipoprotein E polymorphism. Clin Chim Acta. 224:1994;131-137.
14. Hulette C., Nochlin D., McKeel D., et al. Clinical-neuropathologic findings in multi-infarct dementia a report of six autopsied cases . Neurology. 48:1997;668-672.
15. Launer L.J., Masaki K., Petrovitch H., Foley D., Havlik R.J. The association between midlife blood pressure level and late-life cognitive function the Honolulu-Asia Aging Study . JAMA. 274:1995;1846-1851.
16. Lindsay J., Hebert R., Rockwood K. The Canadian study of health and aging risk factors for vascular dementia . Stroke. 28:1997;526-530. Abstract.
17. Manolio T.A., Kronmal R.A., Burke G.L., et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke. 25:1994;318-327.
18. Marin D.B., Breuer B., Marin M.L., et al. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis. 140:1998;173-180.
19. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease . Neurology. 34:1984;939-944.
20. Meguro K., Matsushita M., Yoshida R., et al. A clinicopathological study of senile dementia of Alzheimer's type (SDAT) and white matter lesions of Binswanger's type. Nippon Ronen Igakkai Zasshi. 31:1994;226-231.
21. Morris C.M., Benjamin R., Leake A., et al. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians. Neurosci Lett. 201:1995;45-47.
22. Petrovitch H., Nelson J., Snowdon D., et al. Microscope field size and the neuropathologic criteria for Alzheimer's disease. Neurology. 49:1997;1175-1176.
23. Ross G.W., Launer L.J., Petrovitch H., Masaki K.H., Foley D.J., White L.R. The association between mid life blood pressure and dementia the Honolulu-Asia Aging Study . Neurology. 50:1998;A229. Abstract.
24. Salerno J.A., Murphy D.G.M., Horwitz B., et al. Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. Hypertension. 20:1992;340-348.
25. Savazzi G.M., Cusmano F., Bergamaschi E., Vinci S., Allegri L., Garini G. Hypertension as an etiopathological factor in the development of cerebral atrophy in hemodialyzed patients. Nephron. 81:1999;17-24.
26. Skoog I., Lernfelt B., Landahl S., et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 347:1996;1141-1145.
27. Sparks D.L. Coronary artery disease, hypertension, ApoE, and cholesterol a link to Alzheimer's disease? Ann NY Acad Sci. 826:1997;128-146.
28. Sparks D.L., Scheff S., Liu H., Landers T.M., Coyne C.M., Hunsaker J.C. III. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci. 131:1995;162-169.
29. Sparks D.L., Scheff S.W., Liu H., et al. Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele comparison to confirmed Alzheimer's disease patients . J Neurol Sci. 138:1996;97-104.
30. Strassburger T.L., Lee H.C., Daly E.M., et al. Interactive effects of age and hypertension on volumes of brain structures. Stroke. 28:1997;1410-1417.
31. Swan G.E., DeCarli C., Miller B.L., et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology. 51:1998;986-993.
32. Tatemichi T.K., Desmond D.W., Prohovnik I., et al. Confusion and memory loss from capsular genu infarction a thalamocortical disconnection syndrome? [see comments] Neurology. 42:1992;1966-1979.
33. Tekirian T.L., Saido T.C., Markesbery W.R., et al. N-terminal hetergeneity of parenchymal and cerebrovascular Aβ deposits. J Neuropathol Exp Neurol. 57:1998;76-94.
34. Warzok R.W., Kessler C., Apel G., et al. Apolipoprotein E4 promotes incipent Alzheimer pathology in the elderly. Alzheimer Dis Assoc Disord. 12:1998;33-39.
35. White L., Petrovitch H., Ross G.W., et al. Prevalence of dementia in older Japanese-American men in Hawaii the Honolulu-Asia Aging Study . JAMA. 276:1996;955-960.
36. Yamano S., Sawai F., Morimotot M., et al. A longitudinal study of brain atrophy and its relation with background factors and common carotid hemodynamics. Nippon Ronen Igakkai Zasshi. 31:1994;961-968.
37. Yamano S., Sawai F., Yamamoto Y., et al. Relationship between brain atrophy estimated by a longitudinal computed tomography study and blood pressure control in patients with essential hypertension. Jpn Circ J. 63:1999;79-84.
38. Yoshimura M., Yamanouchi H., Kuzuhara S., et al. Dementia in cerebral amyloid angiopathy a clinicopathological study . J Neurol. 239:1992;441-450.